Here, we found that HCC patients with low level of STK17B and high level of miR-455-3p displayed higher survival rates as compared with patients expressing high level of STK17B and low level of miR-455-3p (Fig. 7b, c). This evidence concerns the gene STK17B and hepatocellular carcinoma.